Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus

doi:10.4254/wjh.v12.i12.1326

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5801)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

376

WORD

HTML

2146

Figures (1-2)

188

Tables (1-4)

201

Sum=3010

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

308

Download

703

Sum=1011

Publishing Process of This Article

Item

Count

Browse

634

Download

1146

Sum=1780

Dec 27, 2020 (publication date) through May 3, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Hepatol. Dec 27, 2020; 12(12): 1326-1340
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1326

Open in New Tab Full Size Figure Download Figure

Figure 1 Data were obtained from 214 patients between December 2011 and December 2013; 18 were excluded from the analysis. eGFR: Estimated glomerular filtration rate; ETV: Entecavir; HBV: Hepatitis B virus; IFN: Interferon alpha; TDF: Tenofovir disoproxil; SPT: Subclinical proximal tubulopathy.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan Meier curves for free subclinical proximal tubulopathy survival among the different groups (entecavir, naive, tenofovir disoproxil). ETV: Entecavir; TDF: Tenofovir disoproxil.

Citation: Brayette A, Essig M, Carrier P, Debette-Gratien M, Labrunie A, Alain S, Maynard M, Ganne-Carrié N, Nguyen-Khac E, Pinet P, De Ledinghen V, Renou C, Mathurin P, Vanlemmens C, Di Martino V, Gervais A, Foucher J, Isabelle FH, Vergniol J, Hourmand-Ollivier I, Cohen D, Duval X, Poynard T, Bardou M, Abergel A, Dao MT, Thévenot T, Hiriart JB, Canva V, Lassailly G, Aurières C, Boyer N, Thabut D, Bernard PH, Schnee M, Larrey D, Hanslik B, Hommel S, Jacques J, Loustaud-Ratti V. Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus. World J Hepatol 2020; 12(12): 1326-1340
URL: https://www.wjgnet.com/1948-5182/full/v12/i12/1326.htm
DOI: https://dx.doi.org/10.4254/wjh.v12.i12.1326